As per corporate shareholdings filed for May-2025, people matching Sofinnova Ventures publicly holds 69 stocks with a net worth of over US$ 2.2 B.
These are shares held by Sofinnova Ventures as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
| Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
|---|---|---|---|---|---|---|---|---|
| Immunogen, Inc. | Sofinnova Ventures | 31.23 | 2,045,202 | 0.73% | 0.00 | 63.9 M | ||
| Reata Pharmaceuticals Inc - Ordinary Shares - Class A | Sofinnova Ventures | 172.36 | 322,471 | 0.85% | 0.00 | 55.6 M | ||
| Cymabay Therapeutics Inc | Sofinnova Ventures | 32.48 | 1,411,769 | 1.23% | 0.00 | 45.9 M | ||
| Karuna Therapeutics Inc | Sofinnova Ventures | 329.83 | 1,381,149 | 3.62% | 0.00 | 455.5 M | ||
| NuCana plc - ADR | Sofinnova Ventures | 0.04 | 4,684,120 | 8.27% | 0.00 | 187.4 K | ||
| Inhibrx Inc | Sofinnova Ventures | 22.50 | 1,302,645 | 2.49% | 0.00 | 29.3 M | ||
| ShockWave Medical Inc | Sofinnova Ventures | 0.00 | 35,000 | 0.09% | 0.00 | - | ||
| Fusion Pharmaceuticals Inc | Sofinnova Ventures | 0.00 | 157,172 | 0.18% | 0.00 | - | ||
| Axonics Inc | Sofinnova Ventures | 70.98 | 150,490 | 0.29% | 0.00 | 10.7 M | ||
| Marinus Pharmaceuticals Inc | Sofinnova Ventures | 0.55 | 4,386,177 | 7.94% | 0.00 | 2.4 M | ||
| Inari Medical Inc | Sofinnova Ventures | 79.97 | 90,327 | 0.15% | 0.00 | 7.2 M | ||
| Jade Biosciences Inc | Sofinnova Ventures | 6.88 | 3,758,686 | 12.97% | 0.00 | 25.9 M | ||
| Akero Therapeutics Inc | Sofinnova Ventures | 48.24 | 510,020 | 0.64% | 0.00 | 24.6 M | ||
| Alnylam Pharmaceuticals Inc | Sofinnova Ventures | 397.75 | 176,181 | 0.14% | 0.00 | 70.1 M | ||
| AnaptysBio Inc | Sofinnova Ventures | 24.71 | 1,160,033 | 3.95% | 0.00 | 28.7 M | ||
| ArriVent BioPharma Inc. | Sofinnova Ventures | 19.36 | 1,696,752 | 4.96% | 0.00 | 32.8 M | ||
| Axsome Therapeutics Inc | Sofinnova Ventures | 102.00 | 175,317 | 0.36% | 0.00 | 17.9 M | ||
| BridgeBio Pharma Inc | Sofinnova Ventures | 47.49 | 734,227 | 0.39% | 0.00 | 34.9 M | ||
| BioAge Labs Inc. | Sofinnova Ventures | 4.46 | 2,304,901 | 6.43% | 0.00 | 10.3 M | ||
| Bristol-Myers Squibb Co. | Sofinnova Ventures | 44.10 | 371,497 | 0.02% | 0.00 | 16.4 M | ||
| Bolt Biotherapeutics Inc | Sofinnova Ventures | 5.89 | 2,754,437 | 7.18% | 0.00 | 16.2 M | ||
| Blueprint Medicines Corp | Sofinnova Ventures | 129.46 | 261,039 | 0.40% | 0.00 | 33.8 M | ||
| Cogent Biosciences Inc | Sofinnova Ventures | 11.51 | 2,182,121 | 1.98% | 0.00 | 25.1 M | ||
| Danaher Corp. | Sofinnova Ventures | 201.69 | 58,606 | 0.01% | 0.00 | 11.8 M | ||
| Dexcom Inc | Sofinnova Ventures | 83.66 | 395,975 | 0.10% | 0.00 | 33.1 M | ||
| Dyne Therapeutics Inc | Sofinnova Ventures | 9.64 | 716,896 | 0.70% | 0.00 | 6.9 M | ||
| Enliven Therapeutics Inc | Sofinnova Ventures | 18.92 | 33,547 | 0.06% | 0.00 | 634.7 K | ||
| Erasca Inc | Sofinnova Ventures | 1.46 | 1,877,085 | 0.66% | 0.00 | 2.7 M | ||
| Establishment Labs Holdings Inc | Sofinnova Ventures | 41.01 | 28,675 | 0.10% | 0.00 | 1.2 M | ||
| Edgewise Therapeutics Inc | Sofinnova Ventures | 14.39 | 342,218 | 0.33% | 0.00 | 4.9 M | ||
| Gilead Sciences, Inc. | Sofinnova Ventures | 115.02 | 418,900 | 0.03% | 0.00 | 48.2 M | ||
| Structure Therapeutics Inc - ADR | Sofinnova Ventures | 17.76 | 34,952 | 0.06% | 0.00 | 620.7 K | ||
| Ideaya Biosciences Inc | Sofinnova Ventures | 24.80 | 2,622,192 | 2.99% | 0.00 | 65.0 M | ||
| ImageneBio Inc. | Sofinnova Ventures | 15.29 | 382,616 | 0.79% | 0.00 | 5.9 M | ||
| Immunome Inc | Sofinnova Ventures | 10.40 | 788,666 | 0.91% | 0.00 | 8.2 M | ||
| Immatics N.V | Sofinnova Ventures | 6.51 | 1,554,304 | 1.28% | 0.00 | 10.1 M | ||
| Incyte Corp. | Sofinnova Ventures | 76.25 | 357,800 | 0.18% | 0.00 | 27.3 M | ||
| Insmed Inc | Sofinnova Ventures | 107.64 | 304,254 | 0.16% | 0.00 | 32.7 M | ||
| Inhibrx Biosciences Inc. | Sofinnova Ventures | 22.99 | 697,916 | 4.82% | 0.00 | 16.0 M | ||
| Inozyme Pharma Inc | Sofinnova Ventures | 4.00 | 4,280,308 | 6.63% | 0.00 | 17.1 M | ||
| Disc Medicine Inc | Sofinnova Ventures | 60.08 | 7,485 | 0.02% | 0.00 | 449.7 K | ||
| Intuitive Surgical Inc | Sofinnova Ventures | 489.93 | 11,984 | 0.00% | 0.00 | 5.9 M | ||
| Jazz Pharmaceuticals plc | Sofinnova Ventures | 116.00 | 510,050 | 0.84% | 0.00 | 59.2 M | ||
| Kura Oncology Inc | Sofinnova Ventures | 6.23 | 791,667 | 0.91% | 0.00 | 4.9 M | ||
| Lilly(Eli) & Co | Sofinnova Ventures | 759.24 | 52,800 | 0.01% | 0.00 | 40.1 M | ||
| Medtronic Plc | Sofinnova Ventures | 91.24 | 562,992 | 0.04% | 0.00 | 51.4 M | ||
| Metsera Inc. | Sofinnova Ventures | 33.90 | 36,800 | 0.04% | 0.00 | 1.2 M | ||
| Natera Inc | Sofinnova Ventures | 136.56 | 1,550,280 | 1.14% | 0.00 | 211.7 M | ||
| Nextcure Inc | Sofinnova Ventures | 4.85 | 2,671,856 | 9.53% | 0.00 | 13.0 M | ||
| Penumbra Inc | Sofinnova Ventures | 256.24 | 42,936 | 0.11% | 0.00 | 11.0 M | ||
| Praxis Precision Medicines Inc | Sofinnova Ventures | 55.55 | 157,640 | 0.77% | 0.00 | 8.8 M | ||
| PTC Therapeutics Inc | Sofinnova Ventures | 51.52 | 579,339 | 0.73% | 0.00 | 29.8 M | ||
| uniQure N.V. | Sofinnova Ventures | 14.18 | 545,771 | 1.00% | 0.00 | 7.7 M | ||
| Rapport Therapeutics Inc. | Sofinnova Ventures | 14.73 | 1,995,594 | 5.47% | 0.00 | 29.4 M | ||
| Arcus Biosciences Inc | Sofinnova Ventures | 9.31 | 1,037,776 | 0.98% | 0.00 | 9.7 M | ||
| Replimune Group Inc | Sofinnova Ventures | 7.08 | 2,479,939 | 3.22% | 0.00 | 17.6 M | ||
| Avidity Biosciences Inc | Sofinnova Ventures | 36.88 | 379,931 | 0.32% | 0.00 | 14.0 M | ||
| Roivant Sciences Ltd | Sofinnova Ventures | 11.35 | 1,279,510 | 0.19% | 0.00 | 14.5 M | ||
| Rhythm Pharmaceuticals Inc. | Sofinnova Ventures | 85.18 | 446,839 | 0.70% | 0.00 | 38.1 M | ||
| Soleno Therapeutics Inc | Sofinnova Ventures | 85.33 | 484,471 | 1.18% | 0.00 | 41.3 M | ||
| Syndax Pharmaceuticals Inc | Sofinnova Ventures | 9.82 | 2,275,223 | 2.64% | 0.00 | 22.3 M | ||
| Sarepta Therapeutics Inc | Sofinnova Ventures | 17.27 | 327,618 | 0.33% | 0.00 | 5.7 M | ||
| Scholar Rock Holding Corp | Sofinnova Ventures | 37.89 | 116,117 | 0.12% | 0.00 | 4.4 M | ||
| Supernus Pharmaceuticals Inc | Sofinnova Ventures | 34.92 | 520,678 | 0.93% | 0.00 | 18.2 M | ||
| Savara Inc | Sofinnova Ventures | 2.56 | 5,481,666 | 3.17% | 0.00 | 14.0 M | ||
| Stryker Corp. | Sofinnova Ventures | 399.04 | 298,567 | 0.08% | 0.00 | 119.1 M | ||
| Vera Therapeutics Inc - Ordinary Shares - Class A | Sofinnova Ventures | 20.62 | 2,793,987 | 4.38% | 0.00 | 57.6 M | ||
| Vir Biotechnology Inc | Sofinnova Ventures | 5.20 | 83,010 | 0.06% | 0.00 | 431.7 K | ||
| Y-Mabs Therapeutics Inc | Sofinnova Ventures | 4.75 | 2,194,278 | 4.84% | 0.00 | 10.4 M |